Richter Announces Submission to European Medicines Agency for Type II Variation Application for RYEQO® for the Treatment of Endometriosis
25/10/2022
Business related Women's Healthcare Marketing authorization application PARTNER - MYOVANT PRODUCT - RYEQO
528 kb 25/10/2022 pdf